Psychiatry & Neurology Doctors in Seaford, DE Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Raju Maharjan, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Rawlins Drive, Seaford, DE 19973 Phone: 302-629-5193

Gina Kay Alderson, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 24488 Sussex Hwy, Unit 6, Seaford, DE 19973 Phone: 302-628-7730    Fax: 302-628-7791

Dr. Jeanette M. S. Zaimes, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 308 E. Stein Hwy, Seaford, DE 19973 Phone: 302-628-7781    Fax: 302-628-7783

Dr. Randy Ord Rummler, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 306 E Stein Hwy, Seaford, DE 19973 Phone: 302-628-1549    Fax: 302-628-9043

Bruce Michael Dopler, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 24488 Sussex Hwy, Unit 6, Seaford, DE 19973 Phone: 302-628-7730    Fax: 302-628-7791

News Archive

Simple test and an MRI predicts future Alzheimer's disease

Until now is has been believed that Alzheimer's disease and other forms of dementia could be diagnosed only when symptoms appear which almost always means when patients are in their 70s or 80s. Now the latest research shows that some brain lesions are characteristic of Alzheimer's disease and can be detected in the brains of healthy people in their 40s. Along with this a simple mental skills test may be able to detect the problem many years sooner than previously thought.

Phase 1 study of STX107 for Fragile X syndrome begins

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers.

RegeneRx receives patent for Tβ4 to prevent immunological responses from toxic agents

RegeneRx Biopharmaceuticals, Inc. announced that the Company received a patent in Australia using thymosin beta 4 (Tβ4), and various fragments and anologues of Tβ4, to treat or prevent biological and immunological responses to reactive chemical, biological or toxic agents.

Creating rituals to honor the dead at long-term-care facilities

One by one, their names were recited as family members clutched one another's hands and silently wept.

External beam partial breast irradiation most cost-effective treatment for women with early-stage breast cancer

External beam partial breast irradiation (EB-PBI) is the most cost-effective method for treating postmenopausal women with early-stage breast cancer based on utilities, recurrence risks and costs when compared to whole breast radiotherapy (WBRT) and brachytherapy partial breast irradiation (brachy-PBI), according to a study in the June 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

Read more Medical News

› Verified 8 days ago